Whole-exome sequencing of 3,964 people with obsessive-compulsive disorder, chronic tic disorders or both identified 36 high-confidence large-effect risk genes—but the result does not create a diagnostic genetic test.

Published: September 1, 2026, 9:30 p.m. PKT · Reporting cutoff: September 1, 2026, 9:15 p.m. PKT

What you need to know

  • The study analyzed 3,964 affected individuals, including 2,418 parent-child trios, and compared them with 1,734 control trios.
  • Researchers focused on rare protein-altering variants, including mutations that appeared in a child but not either parent.
  • The analysis identified 36 high-confidence genes associated with OCD and chronic tic disorders.
  • Some implicated genes overlap with genes previously linked to autism or schizophrenia.
  • The genes influence risk at a population level; they do not determine whether an individual has or will develop a disorder.

A large international genetics study has expanded the list of rare, large-effect genes linked to obsessive-compulsive disorder and chronic tic disorders from a handful to 36. The result offers researchers new routes into the biology shared by conditions that often appear together.

It does not mean scientists have found “the OCD gene.” Both OCD and chronic tic disorders arise from complex combinations of genetic susceptibility, development and environment. The newly identified variants are important clues, not deterministic labels.

How researchers found the 36 risk genes

The team used whole-exome sequencing, which reads the protein-coding portions of the genome. The analysis included 3,964 affected people and placed particular weight on 2,418 trios consisting of an affected child and both biological parents. Researchers also examined 1,734 control trios.

Trio data can reveal de novo variants—changes present in a child but absent from both parents. The team also analyzed rare inherited variants predicted to disrupt protein function. When damaging changes occur more often in affected participants than expected, genes carrying those variants become candidates for further study.

The statistical analysis produced 36 high-confidence large-effect risk genes at the study’s stated false-discovery threshold. Four had already been linked convincingly to these conditions, so most of the list expands the field’s catalog.

Shared biology may explain why the conditions overlap

OCD involves intrusive thoughts and repetitive behaviors; chronic tic disorders, including Tourette syndrome, involve repeated movements or vocalizations that are difficult to control. They frequently co-occur in people and families.

Many genes in the new analysis were shared across diagnostic groups. Gene-expression and network analyses pointed toward brain systems involved in movement, decision-making and habit formation, including cortical and striatal circuits. Several genes have also been implicated in autism or schizophrenia, suggesting that different diagnoses can share parts of their developmental biology without being the same condition.

Why this is not a clinical genetic test

Even a large effect in genetic research does not mean one variant predicts a person’s future with certainty. These rare variants explain only a minority of cases, and many people with OCD or a tic disorder will not carry one of them. Conversely, carrying a risk variant does not guarantee symptoms.

The study also does not justify changing medication or treatment. Potential drug targets must be validated through laboratory work, safety testing and clinical trials. People concerned about symptoms should seek assessment from a qualified clinician rather than interpret consumer genetic data.

How other headlines framed it

  • Nature Neuroscience leads with the sequencing method and the identification of 36 large-effect risk genes.
  • Rutgers University emphasizes shared biological pathways and possible long-term directions for treatment research.
  • Medical Xpress foregrounds the number of genes and the connection between OCD and tic disorders.

What scientists need to do next

Larger and more diverse datasets can test whether the associations hold across ancestries and clinical subtypes. Researchers must also learn where and when each gene acts during brain development, and whether changing those pathways can help without causing harm elsewhere.

Bottom line: The study substantially expands the genetic map of OCD and tic disorders. Its immediate value is biological understanding—not diagnosis or a near-term cure.

Sources

  1. Wang et al., “Whole-exome sequencing in individuals with obsessive–compulsive disorder and chronic tic disorders identifies 36 large-effect risk genes,” Nature Neuroscience, September 1, 2026.
  2. Rutgers University research summary, August 31, 2026.

Editorial disclosure: The lead image is an original conceptual illustration of genetic risk and neural circuitry, not a brain scan, patient image or diagnostic graphic. This article provides science reporting, not medical advice. SciQuest received no payment for this coverage. To report a possible error, contact SciQuest.